Cargando…

A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir(®)

Patient: Male, 59 Final Diagnosis: Chromophobe renal cell carcinoma, stage IV Symptoms: Discomfort in the right hypochondrium Medication: Oncolytic virus Rigvir Clinical Procedure: Nephro-adrenalectomy Specialty: Oncology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Renal cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ismailov, Zaurbek, Rasa, Agnija, Bandere, Katrīna, Brokāne, Linda, Tilgase, Andra, Olmane, Evija, Nazarovs, Jurijs, Alberts, Pēteris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340265/ https://www.ncbi.nlm.nih.gov/pubmed/30635548 http://dx.doi.org/10.12659/AJCR.912115

Ejemplares similares

Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
por: Tilgase, Andra, et al.
Publicado: (2018)

Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient
por: Brokāne, Linda, et al.
Publicado: (2019)

Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report
por: Proboka, Guna, et al.
Publicado: (2019)

Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
por: Proboka, Guna, et al.
Publicado: (2020)

Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
por: Tilgase, Andra, et al.
Publicado: (2020)

Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report
por: Proboka, Guna, et al.
Publicado: (2018)

A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
por: Sorokins, Vladimirs, et al.
Publicado: (2020)

ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report
por: Jaunalksne, Inta, et al.
Publicado: (2020)

Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
por: Tilgase, Andra, et al.
Publicado: (2018)

Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(®) therapy: A case report
por: Pumpure, Elizabete, et al.
Publicado: (2020)

4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period
por: Piwoni, Katarzyna, et al.
Publicado: (2021)

Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
por: Doniņa, Simona, et al.
Publicado: (2015)

Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525
por: Alberts, Pēteris
Publicado: (2022)

Erratum: Melanoma Unknown Primary Brain Metastasis Treatment With ECHO-7 Oncolytic Virus Rigvir: A Case Report
Publicado: (2018)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
por: Babiker, Hani M, et al.
Publicado: (2017)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
por: Babiker, HM, et al.
Publicado: (2019)

Genome Sequences of RIGVIR Oncolytic Virotherapy Virus and Five Other Echovirus 7 Isolates
por: Hietanen, Eero, et al.
Publicado: (2018)

Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates
por: Hietanen, Eero, et al.
Publicado: (2022)

Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report: Erratum
Publicado: (2019)

Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC
por: Lin, Tsu-Feng, et al.
Publicado: (2019)

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers
por: Līcīte, Baiba, et al.
Publicado: (2021)

Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System
por: Weinzierl, Elizabeth P, et al.
Publicado: (2014)

Reply to Alberts, P. Comment on “Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir(®) Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525”
por: Hietanen, Eero, et al.
Publicado: (2022)

Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers
por: Niciporuka, Rita, et al.
Publicado: (2021)

Intracerebral Plasmacytoma in a Patient with HIV-1 Infection and SARS-CoV-2 Superinfection
por: Nazarovs, Jurijs, et al.
Publicado: (2022)

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685
por: Alberts, Pēteris
Publicado: (2020)

Comment on: Malfitano, A.M. et al. “Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Alberts, Pēteris
Publicado: (2020)

Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma
por: Safavi, Moeinadin, et al.
Publicado: (2016)

Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
por: Lichtbroun, Benjamin J., et al.
Publicado: (2023)

Intravesical recurrence of chromophobe renal cell carcinoma
por: Kelly, Niall P., et al.
Publicado: (2023)

Targeting the mTOR pathway in Chromophobe Kidney Cancer
por: Shuch, Brian, et al.
Publicado: (2012)

Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)

Sarcomatoid Chromophobe Renal Cell Carcinoma with Heterologous Component
por: Bharti, Sushma, et al.
Publicado: (2020)

Chromophobe Renal Cell Carcinoma of a Renal Allograft
por: Saparbay, Jamilya, et al.
Publicado: (2021)

Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma
por: Kojima, Fumiyoshi, et al.
Publicado: (2021)

Incidental Eosinophilic Chromophobe Renal Cell Carcinoma in Renal Allograft
por: Alharbi, Abdullah, et al.
Publicado: (2017)

Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
por: Drendel, Vanessa, et al.
Publicado: (2018)

Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2022)

Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients’ plasma
por: Niedra, Helvijs, et al.
Publicado: (2022)

Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
por: Fúnez, Rafael, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_mbl79qav2hk0ba2enakg3h30ma